lenvatinib and everolimus for advanced rcc
Published 4 years ago • 505 plays • Length 5:32Download video MP4
Download video MP3
Similar videos
-
1:19
phase 2 trial of lenvatinib and everolimus for metastatic renal cell carcinoma
-
2:37
lenvatinib/everolimus in refractory mrcc
-
2:40
efficacy and safety of lenvatinib/everolimus in mrcc
-
1:32
three-arm trial of lenvatinib and everolimus for metastatic renal cell carcinoma
-
2:51
practical experience with lenvatinib/everolimus in rcc
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
6:42
the role of lenvatinib in advanced rcc
-
10:06
lenvatinib and pembrolizumab compared to sunitinib for advanced renal cell carcinoma
-
0:45
dr. choueiri on fda approval of lenvatinib/everolimus in rcc
-
4:15
lenvatinib and everolimus for the treatment of rcc
-
3:39
managing patients on lenvatinib/everolimus in mrcc
-
1:40
phase iii meteor trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
-
1:15
q-twist of lenvatinib everolimus in advanced rcc
-
4:05
lenvatinib increases progression free survival with everolimus in metastatic renal cell carcinoma
-
3:42
lenvatinib and everolimus in relapsed/refractory mrcc
-
2:13
dr. hutson on lenvatinib/everolimus combo in rcc
-
0:49
clear: lenvatinib and pembrolizumab in advanced renal cell carcinoma
-
7:03
lenvatinib breakthrough designation, new drug applications for nsclc and sts, and more
-
2:27
role for everolimus in mrcc treatment?